Overview * Plus Therapeutics ( PSTV ) Q3 net loss widens to $4.4 mln from $2.9 mln last year * Company received $1.9 mln advance from CPRIT for radiotherapeutic development * Announced national coverage agreement with UnitedHealthcare for CNSide diagnostics Outlook * Plus Therapeutics ( PSTV ) plans to expand commercial team and footprint for CNSide in Q4 * Company...

Overview * Strategy Q3 net income of $2.8 bln, diluted EPS of $8.42 * Company Q3 revenue of $128.7 mln, surpassing analyst expectations * Strategy reaffirms FY2025 guidance with $34 bln operating income, $24 bln net income Outlook * Strategy reaffirms FY2025 operating income guidance of $34 bln * Company maintains FY2025 net income target of $24 bln * Strategy...

04:34 PM EDT, 10/30/2025 (MT Newswires) -- Christopher Hatto, Vice President & Chief Accounting Officer, on October 28, 2025, sold 15,697 shares in General Motors ( GM ) for $1,098,790. Following the Form 4 filing with the SEC, Hatto has control over a total of 12,007 common shares of the company, with 12,007 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1467858/000129215325000005/xslF345X05/wk-form4_1761855861.xml ...

Overview * ACCO Brands ( ACCO ) Q3 net sales fell 8.8%, missing analyst expectations * Adjusted EPS for Q3 was $0.21, in line with company outlook * Company achieved over $50 mln in savings from cost reduction program Outlook * Company expects full-year 2025 sales to decline 7.0% to 8.5% * ACCO Brands ( ACCO ) forecasts 2025 adjusted...